Cellicure, Inc. provides innovative cell-based immunotherapy technologies, customized treatment regimens and real-world solutions for the current unmet therapeutic needs created by cancer, infectious diseases, and chronic inflammatory diseases. Our multiple groundbreaking CAR-NK technology platforms break through the current major challenges and bottlenecks of cell therapy development and industrialization, bringing significant competitive advantages. Partnering with Memorial Sloan Kettering Cancer Center (MSKCC), Cellicure’s innovative T cell engineering technology – the nCAR-T system, significantly enhances T cell infiltration and survival in tumor microenvironment, thus achieving better efficacies in the treatment of both solid tumors and hematological cancers.
Company Details
- Founded
- 2021
- Address
- 20400 Century Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellicure.com
- HQ
- Germantown, Maryland
Cellicure, Inc. Questions
Cellicure, Inc.'s website is http://www.cellicure.com
Cellicure, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cellicure-inc
Cellicure, Inc.'s industry is
Biotechnology Research
Cellicure, Inc.'s top competitors are
Cartesian Therapeutics,
Immunomic Therapeutics, Inc.,
Hepanova, Inc.,
Regenxbio,
Alliance For Cell Therapy Now,
Pinion Immunotherapeutics,
Emergent Biosolutions,
I.e. Advising, Llc,
Dqv Bioanalytical, Llc,
Enquyst Technologies Inc.
Cellicure, Inc.'s categories are Biotechnology Research
Cellicure, Inc.'s founding year is 2021
